BioSpace News Archive

The Board of Directors of B. Braun of America Inc. announced that they have appointed Rob Albert as Chief Executive Officer of B. Braun of America, succeeding Jean-Claude Dubacher who is taking on global management responsibilities, while remaining Chairman of the Board of B. Braun of America.

AIM ImmunoTech Inc. today announced that it has received authorization from the Erasmus Medical Center (“Erasmus MC”) Ethics Committee to open a European site for the ongoing Phase 2 study (“AMP-270”) of Ampligen as a therapy for locally advanced pancreatic cancer.

Capricor Therapeutics today announced that Capricor’s proprietary StealthX™ exosome-based multivalent vaccine (StealthX™ vaccine) for the prevention of SARS-CoV-2 has been selected to be part of Project NextGen, an initiative by the U.S. Department of Health and Human Services to advance a pipeline of new, innovative vaccines providing broader and more durable protection for COVID-19.

Boncha Bio has recently published a comprehensive White Paper , introducing ‘Candyceutical’ - a revolutionary, all-in-one solution in the health supplements industry.

Alcami Corporation announced the opening of its new 65,000 ft² state-of-the-art Pharma Storage and Services operations facility in Garner, North Carolina close to the Research Triangle Park biotech and pharma hub.

Our latest Research Annual Report, online now, recounts a remarkable year of scientific advancement supported by a record-high level of research funding from federal, state, industry and philanthropic sources.

IlluminOss Medical announces it has reached the important benchmark of having placed 10,000 of its patient conforming implants designed for the treatment of geriatric fractures.

DNA Nanobots, a leader in the design and delivery of DNA nanoparticles engineered for targeted therapeutics, announced that it has closed its pre-seed funding round.

Awakn Designates Program AWKN-002 for Alcohol Use Disorders in the US Market

Slingshot Biosciences Inc., a leader in the development of cell mimics for cell therapy, diagnostics, and rare disease research, is proud to announce the addition of Nicolas Barthelemy as its Executive Chair.